Treatment of AD model Tg2576 mice with 15-epi-LXA4 decreased the production of pro-inflammatory mediators (e.g., TNF-α, IL-1β) and at the same time increased the levels of anti-inflammatory proteins (e.g., TGFβ, IL-10) [221]. Here, TGFB1 is linked to Alzheimer disease.